Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Pulmonx Corporation

Pulmonx Corporation (LUNG) Stock Overview

Explore Pulmonx Corporation’s financial performance, market position, analyst ratings, and future outlook.

LUNG●NASDAQ
HealthcareMedical - Devices
$2.26
$0.04(1.74%)
U.S. Market opens in 54h 53m

Pulmonx Corporation (LUNG)

Meyka AI Score

Z

Key Financials

Market Cap95.5M
P/E Ratio-1.97
EPS (TTM)$-1.16
ROE-0.97%
Fundamental Analysis

AI Price Forecasts

1 Month$2.36
3 Months$2.93
1 Year Target$0.00

LUNG Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Pulmonx Corporation (NASDAQ: LUNG) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Pulmonx Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of LUNG on the NASDAQ shows an RSI of 62.74, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Pulmonx Corporation's NASDAQ-traded stock include a P/E ratio of -1.97 and a market capitalization of 95.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of LUNG on the NASDAQ.

Price Performance (NASDAQ: LUNG)

1-Day Change
-1.74%
5-Day Change
3.20%
1-Month Change
77.95%
3-Month Change
46.75%
6-Month Change
49.67%
Year-to-Date (YTD) Change
2.26%
1-Year Change
47.71%
3-Year Change
-78.23%
5-Year Change
-94.13%
All-Time (Max) Change
-94.25%

Contact Information

https://pulmonx.com
650 364 0400
700 Chesapeake Drive, Redwood City, CA, 94063

Company Facts

2,960 Employees
IPO DateOct 1, 2020
CountryUS
Actively Trading

Frequently Asked Questions